France did not report details of supervised field trials, nor complete a quality assessment of such trials. The Authority had to base its statement on the assumption that the supervised field trials are valid and confirm the proposed temporary MRLs. In order to verify the correctness of the assumption, France should update the evaluation report as soon as possible.
Recital 6, Commission Regulation (EU) No 473/2012 of 4 June 2012 amending Annex III to Regulation (…
In force